Tech Company Financing Transactions
Codexis Funding Round
Codexis closed a $37 million Series D financing round on 8/24/2006. Investors included Edbi, Chevron Technology Ventures and FirstMark Capital.
Transaction Overview
Company Name
Announced On
8/24/2006
Transaction Type
Venture Equity
Amount
$37,000,000
Round
Series D
Investors
Proceeds Purpose
Codexis will use the proceeds from the offering to expand its research and development capabilities, furthering the company's strategy of developing its own products for direct sale to the generic pharmaceutical industry.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
200 Penobscot Dr.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
WE ARE BIOCATALYSIS Codexis is a leading developer of biocatalysts. A biocatalyst is an enzyme or microbe that initiates and accelerates a chemical reaction.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Nicols
Chief Financial Officer
Ross Taylor
Browse more venture capital transactions:
Prev: 8/24/2006: iVivity venture capital transaction
Next: 8/24/2006: SemiSouth Laboratories venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record all VC transactions involving tech companies. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs